Table:
begin	end	state
1	15	cytoplasmic
16	34	transmembrane
35	39	non-cytoplasmic
40	62	transmembrane
63	91	cytoplasmic
92	117	transmembrane
118	123	non-cytoplasmic
124	142	transmembrane
143	153	cytoplasmic
154	176	transmembrane
177	196	non-cytoplasmic
197	220	transmembrane
221	240	cytoplasmic
241	260	transmembrane
261	276	non-cytoplasmic
277	298	transmembrane
299	329	cytoplasmic
330	350	transmembrane
351	355	non-cytoplasmic
356	377	transmembrane
378	397	cytoplasmic
398	421	transmembrane
422	426	non-cytoplasmic
427	445	transmembrane
446	456	cytoplasmic

Input:
>BWI76_RS06245
MESSNKLKRGLSTRHIRFMALGSAIGTGLFYGSADAIKMAGPSVLLAYIIGGVAAYIIMR
ALGEMSVHNPAASSFSRYAQDYLGPLAGYITGWTYCFEILIVAIADVTAFGIYMGVWFPA
VPHWVWVLSVVLIICAVNLMSVKVFGELEFWFSFFKVATIIIMILAGFGIIIWGIGNGGQ
PTGIHNLWSNGGFFSNGWLGMVMSLQMVMFAYGGIEIIGITAGEAKDPEKSIPRAINSVP
MRILVFYVGTLFVIMSIYPWNQVGTNGSPFVLTFQHLGITFAASILNFVVLTASLSAINS
DVFGVGRMLHGMAEQGSAPKMFAKTSRRGVPWVTVMVMTIALLFAVYLNYIMPENVFLVI
ASLATFATVWVWIMILLSQIAFRRRLPPEEAKALKFKVPGGVTTTVIGLLFLVFIIGLIG
YHPDTRISLYVGFAWIILLLIGWQFKTRRERKLAKA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server